[Home ] [Archive]    
Main Menu
Home::
Journal Information::
Articles archive::
For Authors::
For Reviewers::
Subscription::
Contact us::
Site Facilities::
Webmail::
::
Search in website

Advanced Search
Receive site information
Enter your Email in the following box to receive the site news and information.
:: Volume 19, Issue 2 (خرداد و تیر 2014) ::
pajoohande 2014, 19(2): 66-77 Back to browse issues page
Effect of intraperitoneal and intrathecal administration of ascorbic acid and sodium ascorbate on pain in rat
Neda Movahhed Avval , Masoud Fereidoni *
Department of Biology, Faculty of Sciences, Ferdowsi University of Mashhad, Mashhad, Iran; Phone: +98 9155242015, Fax: +98 511 8762227 , fereidoni@um.ac.ir
Abstract:   (8468 Views)
Background and Aim: Ascorbic acid (ASC) is abundant in the brain. ASC is effective on synthesis and transportation of neurotransmitters. Glutamatergic system is involved in pain transduction. NMDA receptors can be inhibited, and TPRV1 and ASIC receptors are excited due to its acidity at the presence of ASC. Therefore, this study is aimed to investigate the effects of intraperitoneal (i.p) and intrathecal (i.t) administration of ASC and sodium-ascorbate on pain. Materials and Methods: Male Wistar rats (200-250 g) in eight groups (n=7) included saline (i.p), saline (i.t), ASC (1, 10, 100, 200 mg/kg, i.p), usual and neutralized ASC (0.02 mg/10 μl, i.t) were used. Pain threshold was measured by tail-flick test and chemical pain was assessed using formalin-test. Results: ASC (10, 100, 200 mg/kg, i.p) induced hyperalgesia in tail-flick test (P<0.01) and reduced pain in formalin-test (P<0.05), but ASC (1 mg/kg i.p) with no effect in tail-flick, decreased pain during formalin-test interphase (P<0.01). Intrathecal ASC at 0.02 mg/10 µl concentration, but not sodium-ascorbate, induced hyperalgesia in tail-flick test (P<0.001). ASC (0.02 mg/10 µl, i.t) in both forms of usual and sodium-ascorbate, decreased pain in formalin-test (P<0.001). ‍Conclusion: Lesser inhibition effects of ASC on AMPA receptors may be responsible at least in part for its hyperalgesia in tail-flick test at i.p administration. This plus the sensitivity of TRPV1 and ASIC receptors to ASC acidity can be considered for i.t administration, because sodium-ascorbate (i.t) didn’t induce hyperalgesia. Inhibiting effects of i.p and i.t administration of ASC and sodium-ascorbate on NMDA receptors, release of SP and other inflammatory mediators, were probably some players of pain reduction during the formalin-test.
Keywords: Ascorbic acid, Sodium ascorbate, Pain, Intraperitoneal administration, Intrathecal administration
Full-Text [PDF 886 kb]   (2525 Downloads)    
Type of Study: Original | Subject: Medicine
Received: 2017 | Accepted: 2017 | Published: 2017
Send email to the article author

Add your comments about this article
Your username or Email:

CAPTCHA


XML   Persian Abstract   Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Neda Movahhed Avval, Masoud Fereidoni. Effect of intraperitoneal and intrathecal administration of ascorbic acid and sodium ascorbate on pain in rat . pajoohande 2014; 19 (2) :66-77
URL: http://pajoohande.sbmu.ac.ir/article-1-1729-en.html


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Volume 19, Issue 2 (خرداد و تیر 2014) Back to browse issues page
Persian site map - English site map - Created in 0.05 seconds with 36 queries by YEKTAWEB 4660